What Does Waisman Biomanufacturing Do?

Total employees75
HeadquartersMadison
Founded2001

Waisman Biomanufacturing, part of the Waisman Center at the University of Wisconsin-Madison, is a premier contract development and manufacturing organization (CDMO). It specializes in producing high-quality biologics, including plasmid DNA, recombinant proteins, viral vectors, and cell-based therapeutics, under Current Good Manufacturing Practices (cGMP) for Phase I/II human clinical trials. Catering to academic researchers, biotech startups, and pharmaceutical companies, Waisman Biomanufacturing offers comprehensive services from process development and scale-up to analytical testing and regulatory support, effectively bridging the gap between preclinical research and clinical application of novel therapies.

Where Is Waisman Biomanufacturing's Headquarters?

Waisman Biomanufacturing officeWaisman Biomanufacturing officeWaisman Biomanufacturing officeWaisman Biomanufacturing office
*Images sourced via web search. Rights belong to original owners

HQ Function

Serves as the central hub for all cGMP manufacturing operations, process development, quality control, quality assurance, project management, and business development activities. It houses state-of-the-art cleanroom suites and laboratories.

Notable Features:

Multiple cGMP-compliant cleanroom suites (Grade B/C/D) for viral vector production, cell therapy processing, microbial fermentation, and protein purification. Advanced analytical and quality control laboratories. Proximity to the extensive research resources and expertise of the University of Wisconsin-Madison.

Work Culture:

Characterized by a blend of academic rigor and industry-standard cGMP practices. It fosters a highly collaborative, team-oriented environment where scientists, engineers, and quality professionals work closely on complex biomanufacturing projects. Emphasis is placed on meticulous attention to detail, continuous learning, and a shared mission of advancing human health through innovative therapies.

HQ Significance:

Plays a critical role in the biotechnology ecosystem by enabling the translation of cutting-edge scientific discoveries, particularly from academic and small biotech entities, into clinical-grade materials for human trials. It helps de-risk and accelerate the development of novel therapies.

Values Reflected in HQ: The facility's design, operations, and mission reflect core values of scientific integrity, quality assurance, patient safety, innovation in bioprocessing, and a strong commitment to translating research discoveries into tangible clinical benefits. Its affiliation with a public university underscores a dedication to public service and education.

Location:

While Waisman Biomanufacturing operates from its primary facility in Madison, Wisconsin, its impact and collaborations are global. The facility manufactures products for clients and research partners worldwide, supporting clinical trials conducted in various countries. Its expertise contributes to the international advancement of novel biopharmaceuticals, gene therapies, and cell therapies.

Street Address:

1500 Highland Ave

City:

Madison

State/Province:

Wisconsin

Country:

USA

Where Else Does Waisman Biomanufacturing Operate Around the World?

No additional office locations available.

Buying Intent Signals for Waisman Biomanufacturing

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Waisman Biomanufacturing? Meet the Executive Team

As of April 2025, Waisman Biomanufacturing' leadership includes:

Carl Ross, PhD - Managing Director
Derek Hei, PhD - Technical Director
Sandy Schappe - Quality Assurance Director
Brian Dattilo, PhD - Business Development Director
Chris Jelesnianski, PhD - Project Management Director

Who's Investing in Waisman Biomanufacturing?

Waisman Biomanufacturing has been backed by several prominent investors over the years, including:

University of Wisconsin-Madison
State of Wisconsin funding initiatives
Federal grants (e.g., National Institutes of Health - NIH)
Research foundations
Client-sponsored manufacturing and development projects

What Leadership Changes Has Waisman Biomanufacturing Seen Recently?

Hire0
Exits0

Based on publicly available information, Waisman Biomanufacturing's core leadership team has remained stable, with no major executive hires or departures publicly announced in the last 12 months. The continuity in leadership supports their ongoing strategic initiatives and operational excellence.

What Technology (Tech Stack) Is Used byWaisman Biomanufacturing?

Discover the tools Waisman Biomanufacturing uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Waisman Biomanufacturing Email Formats and Examples

As part of the University of Wisconsin-Madison and the Waisman Center, Waisman Biomanufacturing personnel typically use email addresses associated with the university's domain. Common formats include [last]@[waisman.]wisc.edu or [first_initial][last]@[waisman.]wisc.edu.

[last]@waisman.wisc.edu or [first_initial][last]@wisc.edu

Format

dattilo@waisman.wisc.edu

Example

80%

Success rate

What's the Latest News About Waisman Biomanufacturing?

Waisman Center News • November 9, 2023

Waisman Biomanufacturing Manufactures Novel Treatment for Rare Pediatric Neurodegenerative Disease

Waisman Biomanufacturing announced the successful cGMP manufacturing of ABO-201 (scAAV9.PIGN), a novel gene therapy product developed by Abeona Therapeutics for CLN3 disease, a fatal pediatric neurodegenerative disorder. This achievement underscores Waisman's capability in producing complex viral vectors for clinical use....more

Waisman Center News • June 1, 2023

Waisman Biomanufacturing is Leading the Way on New Treatments for Vision Loss

Waisman Biomanufacturing is collaborating with Opsis Therapeutics to produce cell-based therapies derived from human induced pluripotent stem cells (iPSCs) aimed at treating retinal degenerative diseases. This partnership highlights their role in advancing cutting-edge treatments for vision loss....more

Wisconsin State Journal • February 14, 2023

Know Your Madisonian: Waisman Biomanufacturing's Carl Ross helps move treatments from lab to patient

An article highlighting the role of Carl Ross, Managing Director of Waisman Biomanufacturing, and the facility's critical function in advancing cell and gene therapies from research stages to clinical application, emphasizing its unique position within UW-Madison....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Waisman Biomanufacturing, are just a search away.